PTTG1IP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.319400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.843400E-01
Normal-vs-Stage2
2.879400E-01
Normal-vs-Stage3
7.009600E-01
Normal-vs-Stage4
2.104800E-01
Stage1-vs-Stage2
4.146800E-01
Stage1-vs-Stage3
9.136000E-01
Stage1-vs-Stage4
3.749400E-01
Stage2-vs-Stage3
6.059400E-01
Stage2-vs-Stage4
8.159000E-01
Stage3-vs-Stage4
5.768200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.589400E-01
Normal-vs-AfricanAmerican
4.446600E-01
Normal-vs-Asian
3.032200E-01
Caucasian-vs-AfricanAmerican
9.438200E-01
Caucasian-vs-Asian
6.501800E-01
AfricanAmerican-vs-Asian
7.206200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.562400E-01
Normal-vs-Female
3.013600E-01
Male-vs-Female
5.486600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.886600E-01
Normal-vs-Age(41-60Yrs)
1.358640E-01
Normal-vs-Age(61-80Yrs)
4.684800E-01
Normal-vs-Age(81-100Yrs)
2.409400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.427430E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.814200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.622600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.627700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.370600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.039400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.592600E-01
Normal-vs-Daily Drinker
5.231200E-01
Normal-vs-Weekly Drinker
3.025200E-01
Normal-vs-Occasional Drinker
1.982380E-01
Normal-vs-Social Drinker
3.029000E-01
Non Drinker-vs-Daily Drinker
9.839000E-01
Non Drinker-vs-Weekly Drinker
5.404200E-01
Non Drinker-vs-Occasional Drinker
1.780640E-01
Non Drinker-vs-Social Drinker
6.248000E-01
Daily Drinker-vs-Weekly Drinker
6.627600E-01
Daily Drinker-vs-Occasional Drinker
3.157600E-01
Daily Drinker-vs-Social Drinker
7.311400E-01
Weekly Drinker-vs-Occasional Drinker
5.820000E-01
Weekly Drinker-vs-Social Drinker
9.046800E-01
Occasional Drinker-vs-Social Drinker
4.855000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.050240E-01
Normal-vs-Grade 2
9.503900E-03
Normal-vs-Grade 3
1.057570E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.418740E-04
Grade 1-vs-Grade 3
8.04180000000265E-05
Grade 1-vs-Grade 4
1.050240E-01
Grade 2-vs-Grade 3
3.247600E-01
Grade 2-vs-Grade 4
9.503900E-03
Grade 3-vs-Grade 4
1.057570E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.954000E-01
Normal-vs-NonDiabetic
2.790200E-01
Diabetic-vs-NonDiabetic
2.744200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.931600E-02
Normal-vs-NoPancreatitis
3.873000E-01
Pancreatitis-vs-NoPancreatitis
1.642170E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.826400E-01
Normal-vs-N1
3.017000E-01
N0-vs-N1
8.882200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.632000E-02
Normal-vs-TP53-NonMutant
7.575800E-01
TP53-Mutant-vs-TP53-NonMutant
2.83969999959055E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
